Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
UPDATE: Cantor Fitzgerald Assumes AxoGen, Inc. (AXGN) at Overweight
-
AxoGen, Inc. (AXGN) PT Lowered to $19 at Cantor Fitzgerald
-
Axogen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Axogen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
AxoGen, Inc. (AXGN) PT Lowered to $21 at Cantor Fitzgerald
-
AxoGen, Inc. (AXGN) PT Lowered to $26 at Cantor Fitzgerald
-
AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
AxoGen, Inc. Reports 2018 Second Quarter Financial Results
-
AxoGen, Inc. Reports 2018 Second Quarter Financial Results
-
AxoGen, Inc. (AXGN) PT Raised to $45 at Cantor Fitzgerald
-
Cantor Fitzgerald Assumes AxoGen, Inc. (AXGN) at Overweight
-
AxoGen Announces Closing of Public Offering of Common Stock
-
AxoGen (AXGN) Prices Public Offering of Common Stock at $21/Share
-
AxoGen, Inc. Announces Pricing of Public Offering of Common Stock
-
AxoGen (AXGN) Announces 1M Share Common Offering
-
AxoGen, Inc. Announces Proposed Public Offering of Common Stock
-
AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
AxoGen (AXGN): Key Points From Non Deal Roadshow - Cantor
-
AxoGen, Inc. Reports 2017 Second Quarter Financial Results
-
Cantor Fitzgerald Issues New Coverage On 9 Medical Equipment Names
-
Cantor Fitzgerald Starts AxoGen, Inc. (AXGN) at Overweight
